Skip to content
Search

Latest Stories

Pharmacy trade families to benefit from Leverhulme Trade Charities Trust higher education bursary scheme

Pharmacy trade families to benefit from Leverhulme Trade Charities Trust higher education bursary scheme
Children of employed convenience retailers, supermarket workers, or pharmacy technicians are eligible for the LTCT bursary scheme

The Leverhulme Trade Charities Trust (LTCT) is set to provide financial aid for the families of those working in the convenience, grocery, and pharmacy trades starting next month.

In an announcement, the Trust shared that the applications for the academic year 2024/25 for undergraduate bursaries will start from August 1 till October 15.


LTCT bursary schemes are intended for university students whose parent or carer is "employed in an eligible profession, such as convenience retailer, supermarket store worker, or pharmacy technician".

According to the charity's bursary scheme, successful applicants can receive up to £3,000, which can be put towards tuition fees, course materials, equipments, or even travel costs.

"With the charity’s core belief that everyone should have the opportunity to reach their academic potential", LTCT believes.

The bursary scheme will help alleviate some of the financial pressure on students interested in pursuing higher education and their parents.

In 2024, the total number of bursaries awarded since the scheme launched is expected to exceed 5,000, totalling £28million worth of financial aid.

Professor Anna Vignoles CBE FBA, Director at The Leverhulme Trade Charities Trust (LTCT), announced that the trust is gearing up for one of its busiest and most rewarding periods.

"Our undergraduate bursaries see a high volume of applications year on year, and with every approval, we delight in knowing we’ve helped a student get a little closer to their academic goals," Vignoles said.

She emphasised the trust's belief that everyone deserves the opportunity to continue their educational journey.

Moreover, she expressed hope that the bursaries can help lighten the financial burden for students.

"We therefore encourage anyone in the grocery or pharmacy trade who may be eligible to apply – it could well lead to someone in your family taking the next step in their education. Make sure the 1st of August is in the diary!" she added.

In addition to the undergraduate bursary, LTCT has a postgraduate scheme currently open for those keen to return to university, which closes on the 1st of September, 2024.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less